Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Medicinal Chemistry
|
August 19, 2007
Development of a peptidomimetic ligand for efficient isolation and purification of factor VIII via affinity chromatography
Sebastian Knör, Alexey V Khrenov, Burkhardt Laufer, et al.
ACS Nano
|
July 30, 2014
Encapsidated atom-transfer radical polymerization in Qβ virus-like nanoparticles
Marisa L Hovlid, Jolene L Lau, Kurt Breitenkamp, et al.
Chemmedchem
|
April 8, 2014
The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system
Florian Rechenmacher, Kristin Steigerwald, Burkhardt Laufer, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
January 27, 2012
Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces
Michael Joner, Qi Cheng, Sabine Schönhofer-Merl, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation
Jayanta Chatterjee, Burkhardt Laufer, Johannes G Beck, et al.
Journal of the American Chemical Society
|
June 29, 2012
Intestinal permeability of cyclic peptides: common key backbone motifs identified
Johannes G Beck, Jayanta Chatterjee, Burkhardt Laufer, et al.
Nanoscale
|
May 16, 2012
Guiding plant virus particles to integrin-displaying cells
Marisa L Hovlid, Nicole F Steinmetz, Burkhardt Laufer, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
Development of a small molecule peptidomimetic affinity ligand for efficient purification of the large protein factor VIII
Sebastian Knör, Burkhardt Laufer, Alexey Khrenov, et al.
Journal for Immunotherapy of Cancer
|
July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer
David B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Medicinal Chemistry
|
August 19, 2007
Development of a peptidomimetic ligand for efficient isolation and purification of factor VIII via affinity chromatography
Sebastian Knör, Alexey V Khrenov, Burkhardt Laufer, et al.
ACS Nano
|
July 30, 2014
Encapsidated atom-transfer radical polymerization in Qβ virus-like nanoparticles
Marisa L Hovlid, Jolene L Lau, Kurt Breitenkamp, et al.
Chemmedchem
|
April 8, 2014
The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system
Florian Rechenmacher, Kristin Steigerwald, Burkhardt Laufer, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
January 27, 2012
Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces
Michael Joner, Qi Cheng, Sabine Schönhofer-Merl, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation
Jayanta Chatterjee, Burkhardt Laufer, Johannes G Beck, et al.
Journal of the American Chemical Society
|
June 29, 2012
Intestinal permeability of cyclic peptides: common key backbone motifs identified
Johannes G Beck, Jayanta Chatterjee, Burkhardt Laufer, et al.
Nanoscale
|
May 16, 2012
Guiding plant virus particles to integrin-displaying cells
Marisa L Hovlid, Nicole F Steinmetz, Burkhardt Laufer, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
Development of a small molecule peptidomimetic affinity ligand for efficient purification of the large protein factor VIII
Sebastian Knör, Burkhardt Laufer, Alexey Khrenov, et al.
Journal for Immunotherapy of Cancer
|
July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer
David B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Page
of 2